Cortendo AB 2016 Annual General Meeting / Årsstämma

View Investor Presentation

Corporate Profile

Strongbridge Biopharma is a global biopharmaceutical company focused on the development and commercialization of novel therapies for rare diseases. Founded in 1996, the Company is domiciled in Ireland and based in the United States. The Company is publicly traded on the NASDAQ Global Market under the ticker symbol SBBP.

StronRead More

 |NASDAQ GS SBBP (Common Stock)
$4.80 - 0.2
Stock chart for: SBBP.O.  Currently trading at $4.80 with a 52 week high of $9.21 and a 52 week low of $3.30.
Data provided by Nasdaq. Minimum 15 minutes delayed.

Press Releases

Strongbridge Biopharma plc Announces Appointment of Jeffrey W. Sherman, M.D

October 3, 2016

DUBLIN, Ireland and TREVOSE, Pa., Oct. 03, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global biopharmaceutical company fo....

Read More

Strongbridge Biopharma plc Announces Presentation at Cantor Fitzgerald’s 2n

July 6, 2016

DUBLIN, Ireland and TREVOSE, Pa., July 06, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ:SBBP), a global rare disease biopharmaceutica....

Read More

View More